Sagility Ltd

The company reported a 45.94% increase in consolidated net profit to Rs 216.81 crore on a 27.59% rise in revenue from operations to Rs 1,963.48 crore in Q1 FY27 over Q1 FY26. The company reported profit before exceptional items and tax of Rs 302.57 crore in Q1 FY27, compared with Rs 210.39 crore a year ago. The firm reported exceptional items of Rs 15.09 crore during the quarter. In Q1 FY27, adjusted EBITDA stood at Rs 471.6 crore, up 27.9%, compared with Rs 368.7 crore posted in the same quarter last year. Adjusted EBITDA margin stood at 24% in Q1 FY27 as against 24% in Q1 FY26. In dollar terms, the company reported revenue of $207.8 million, while adjusted PAT stood at $28.6 million in Q1 FY27. In constant currency terms, revenue grew 15.2% YoY, while organic growth came in at 27.3% YoY (14.9% in constant currency). As of 30 June 2026, the company had 47,307 employees and operated 29 delivery centers across five countries. Voluntary attrition stood at 28.6% in Q1 FY27, compared with 27.6% in Q1 FY26. Ramesh Gopalan, managing director and group CEO, said, 'Healthcare organizations are increasingly looking for partners that can combine healthcare expertise with technology, AI, and operational accountability to deliver measurable outcomes. We are seeing growing demand for outcome-oriented managed services engagements, and the early momentum behind Sagility Synchrony reinforces our belief that the future of healthcare operations lies in more integrated, intelligent operating models. Our acquisition of CareSeed further strengthens our capabilities in healthcare quality and expands our reach in the Medicare Advantage and mid-market segments.' Srinivas Mattapalli, Group Chief Financial Officer, added, We have started the year on a strong note, supported by healthy business momentum, resilient profitability and robust cash generation. Our performance reflects the strength of Sagility's healthcare-focused model, the depth of our client relationships and our strong execution across markets. With a strong balance sheet, healthy cash flows and clear strategic priorities, we remain well-placed to invest in growth, strengthen our capabilities and drive sustainable long-term value for our stakeholders.' Sagility is a global provider of technology-enabled business solutions and services to clients in the U.S. healthcare industry.Powered by Capital Market - Live

Net profit of Sagility rose 45.94% to Rs 216.81 crore in the quarter ended June 2026 as against Rs 148.56 crore during the previous quarter ended June 2025. Sales rose 27.59% to Rs 1963.48 crore in the quarter ended June 2026 as against Rs 1538.94 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales1963.481538.94 28 OPM %22.3222.49 - PBDT430.59328.58 31 PBT302.57210.39 44 NP216.81148.56 46 Powered by Capital Market - Live

Sagility will hold a meeting of the Board of Directors of the Company on 21 July 2026.

Sagility announced that the 5th Annual General Meeting(AGM) of the company will be held on 20 August 2026.

The acquisition, approved by the board of directors at its meeting held on June 11, 2026, is a cash transaction. The deal is expected to be completed on the same date. CareSeed, headquartered in Kansas City, Missouri, reported a turnover of USD 5.1 million in CY2025. The company operates in the US healthcare analytics and technology space, offering NCQA-certified HEDIS reporting, medical record review, chart abstraction, and regulatory analytics solutions for health plans. Sagility said the acquisition aligns with its strategy to strengthen healthcare quality measurement and risk adjustment capabilities and expand into STAR performance management and care gap closure services. CareSeed currently serves around 30 mid-sized US health plans, primarily in the Medicare Advantage segment. Its cloud-based platforms, Forecast and Harvest, support HEDIS reporting, audit readiness, and regulatory compliance. The company said the acquisition will enhance its healthcare quality and Stars capabilities and enable expansion into integrated quality orchestration across payer ecosystems. The deal is expected to strengthen Sagility's position in the US healthcare payer market and create cross-selling opportunities across technology and clinical services. Sagility is a global provider of technology-enabled business solutions and services to clients in the U.S. healthcare industry. The company's consolidated net profit jumped 41.2% to Rs 257.73 crore on 29.1% rise in revenue from operations to Rs 2,024.26 crore in Q4 FY26 over Q4 FY25. Powered by Capital Market - Live

Sagility announced that the Board of Directors of the Company at its meeting held on 12 May 2026, inter alia, have recommended the final dividend of Rs 0.1 per equity Share (i.e. 1%) , subject to the approval of the shareholders.

Net profit of Sagility rose 41.17% to Rs 257.73 crore in the quarter ended March 2026 as against Rs 182.57 crore during the previous quarter ended March 2025. Sales rose 29.06% to Rs 2024.26 crore in the quarter ended March 2026 as against Rs 1568.48 crore during the previous quarter ended March 2025. For the full year,net profit rose 71.53% to Rs 924.77 crore in the year ended March 2026 as against Rs 539.12 crore during the previous year ended March 2025. Sales rose 29.14% to Rs 7192.85 crore in the year ended March 2026 as against Rs 5569.92 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales2024.261568.48 29 7192.855569.92 29 OPM %23.9423.78 -24.4723.30 - PBDT487.34353.32 38 1759.091227.09 43 PBT363.18238.99 52 1271.72760.23 67 NP257.73182.57 41 924.77539.12 72 Powered by Capital Market - Live

Sagility will hold a meeting of the Board of Directors of the Company on 12 May 2026.

The company reported profit before exceptional items and tax of Rs 371.34 crore in Q3 FY26, compared with Rs 289.81 crore a year ago. The quarter included exceptional items of Rs 32.82 crore due to a one-time impact from India's new labor codes, effective 21 November 2025, related to long-term employee benefits. In Q3 FY26, adjusted EBITDA stood at Rs 512.5 crore, up 24.2%, compared with Rs 412.7 crore posted in the same quarter last year. Adjusted EBITDA margin stood at 26% in Q3 FY26 as against 28.4% in Q3 FY25. In dollar terms, the company reported revenue of $222 million, while adjusted PAT stood at $36.4 million in Q3 FY26. In constant currency terms, revenue grew 29.1% YoY, while organic growth came in at 19.9% YoY (13.9% in constant currency). As of 31st December 2025, the company had 48,522 employees and operated 35 delivery centers across five countries. Attrition improved to 22.8% in Q3 FY26 as against 21.8% in Q3 FY25. Ramesh Gopalan, managing director and group CEO, said, 'Building on the momentum from the first half of the year, our performance in this quarter has been exceptional. The open enrollment period was particularly successful, with strong outcomes across our large payer relationships. The addition of BroadPath expanded our exposure to open-enrollment-driven work and a broader payer client base. This was supported by disciplined and reliable execution. As clients navigate an evolving regulatory and profitability environment, engagements are increasingly shaped by outcome-oriented delivery models with a strong focus on cost reduction. This shift is clearly reflected in our deal pipeline with more complex constructs anchored in outcomes and efficiency commitments on the back of technology and transformation. Our execution excellence and our continued commitment to helping our clients navigate the immediate challenges place us in a strong position. We remain confident in sustaining this momentum through the final quarter.' Abhishek Kayan, deputy chief financial officer, added, 'This quarter's performance reflects our ability to scale rapidly while maintaining financial discipline. We delivered strong revenue growth without compromising margins, driven by operational excellence, robust cost management, and focused execution across the business. This has enabled us to maintain a healthy balance sheet, progressively reduce debt, and preserve financial flexibility. We will continue to allocate capital selectively, prioritizing investments in AI, domain capabilities, and the development of an AI-ready, healthcare-focused workforce, while maintaining a prudent approach to costs. This balance between financial discipline and strategic investment positions us well to sustain growth and margins and strengthen the long-term economics of the business.' Sagility is a global provider of technology-enabled business solutions and services to clients in the U.S. healthcare industry. Shares of Sagility fell 3.13% to Rs 50.07 on the BSE.Powered by Capital Market - Live

Net profit of Sagility rose 23.40% to Rs 267.66 crore in the quarter ended December 2025 as against Rs 216.91 crore during the previous quarter ended December 2024. Sales rose 35.65% to Rs 1971.15 crore in the quarter ended December 2025 as against Rs 1453.07 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1971.151453.07 36 OPM %25.9326.99 - PBDT494.86405.99 22 PBT371.34289.81 28 NP267.66216.91 23 Powered by Capital Market - Live